...Khaled Alghueiri; Philipp C. Engert; Mohamed Alhabib; Peter Schott; Waseem Arafat; Armin Soave; Martin G. Friedrich Introduction: This study aims to evaluate the effectiveness of prostatic artery embolization (PAE) in treating benign prostatic hyperplasia (BPH), focusing on identifying...

.... Lee SWH , Chan EMC , Lai YK . The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis . Sci Rep . 2017 ; 7 (1): 7984 – 10 . 2. Lerner LB , Mcvary KT , Barry MJ , Bixler BR , Dahm...

... > 0.05). Conclusions: Biofeedback electrical stimulation combined with pelvic floor muscle training is an efficient nonsurgical combination therapy for the symptoms of SUI after HoLEP for benign prostatic hyperplasia. In addition, the recovery of the patient’s psychological state does not coincide...

...Hua Luo; Gaoyuan Liao; Xiaobo Wang; Chao He; Yanghan Liu Introduction: Benign prostatic hyperplasia (BPH) is a common condition in older men, marked by the noncancerous enlargement of the prostate gland. Inflammation of the prostate plays a significant role in the progression of BPH...

... data of 548 patients who underwent HoLEP were retrospectively analyzed. The patients were followed up for the occurrence of urinary incontinence in the short term (2 weeks), medium term (3 months), and long term (6 months) after HoLEP. Results: Among the 548 benign prostatic hyperplasia patients, 79...

...Jianping Liu; Weijian Zhou; Peng Zhang; Wei Zhang; Congwang Chang; Guanghua Fu Background: There is limited research into the efficacy and safety of tadalafil combined with tamsulosin for the treatment of lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH...

...Fabio Crocerossa; Francesco Cantiello; Lorenzo Bagalá; Francesco Sicoli; Umberto Carbonara; Celeste Manfredi; Ugo Falagario; Alessandro Veccia; Savio D. Pandolfo; Luigi Napolitano; Matteo Ferro; Michele Di Dio; Nicola Mondaini; Rocco Damiano Introduction: Benign prostatic hyperplasia (BPH...

...Atanas Ivanov; Petar Antonov; Eleonora Hristova-Atanasova; Petar Uchikov Introduction: Benign prostatic hyperplasia (BPH) is a histological diagnosis characterized by an increase in the number of epithelial and stromal cells in the transitional zone of the prostate gland. The clinical manifestation...

... symptoms. We assessed its safety, efficacy and impact on urinary flow, ejaculation, and quality of life. Materials and Methods: We included 64 men, treated for benign prostate hyperplasia for at least 1 year. All patients had Qmax≤ 13 mL/s and IPSS >12. Insertion of the device was performed via...

...Fulin Zhang; Jinbin Xu; Ciming Sun; Fuyang Dai; Qin Zhu; Hui Liang Background: Benign prostatic hyperplasia (BPH) is a common urological disorder leading to dysuria in middle-aged and elderly men and significantly reduces the quality of life of patients. Technology for BPH has made a great progress...

... patients were discharged if they passed urine successfully after urethral catheter was removed. Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) are very common clinical complaints among older men [1]. In fact, the prevalence of BPH is approximately 50...

...Diaa-Eldin Taha; Ali Ibrahim; Mona Talaat; Tarek Abdelbaky; Hossam Nabeeh Objectives: The aim of this study was to assess whether the duration of preoperative benign prostatic hyperplasia (BPH) medication would affect the pressure flow study (PFS) parameters and the outcome of prostate surgery...

...: ([HoLEP] AND [HoLEP OR Holmium Laser Enucleation of the Prostate] AND [complication OR outcome] AND [benign prostatic hyperplasia OR benign prostatic enlargement OR LUTS OR lower urinary tract symptoms]). The terms “complication” and “adverse events” and “enucleation” and “adenomectomy” were used...

... treatment among men with benign prostatic hyperplasia. Finasteride long-term efficacy and safety study group . N Engl J Med . 1998 ; 338 : 557 – 63 . 10.1056/NEJM199802263380901 . 11. Garvey   B , Türkbey   B , Truong   H , Bernardo   M , Periaswamy   S , Choyke   PL . Clinical...

.... Holmium laser enucleation of the prostate Benign prostatic hyperplasia Transrectal prostate biopsy High-power holmium laser enucleation of the prostate Transurethral enucleation Holmium laser enucleation of the prostate (HoLEP) is the gold standard treatment for benign prostatic hyperplasia...

... Anticholinergics Benign prostatic hyperplasia Overactive Bladder Symptom Score Overactive bladder Subgroup analysis A 52-week course of tamsulosin + dutasteride + imidafenacin (TDI) triple therapy has been reported to demonstrate significantly superior efficacy to a 52-week course of tamsulosin...

...Jian Zhang; Yonghui Wang; Shuang Li; Shipeng Jin; Shiqing Zhang; Chunli Zhao; Wenzeng Yang; Shujin Cui; Yuexin Liu Background: Benign prostatic hyperplasia (BPH) is a common chronic progressive disease resulting in urinary obstruction in aging men. It comes to more and more patients with massive...

... transplantation Vesicoureteral reflex Urological complications Allograft lithiasis Benign prostatic hyperplasia At present, kidney transplantation is undeniably the better option for the treatment of ESRD compared to dialysis. The 5-year survival rate with kidney transplantation, regardless of whether...

... and as surrogate markers for metabolic disease, cardiovascular disease, and malignancies, including prostate cancer. However, scant studies have investigated the association of NLR, PLR, and LMR with benign prostatic hyperplasia (BPH). Methods: Data from 8,727 middle-aged men who had participated in a health...

... records of patients with 80-g or larger prostates who underwent holmium laser enucleation of the prostate (HoLEP), laparoscopic simple prostatectomy (LSP), or open prostatectomy (OP) due to medical treatment-resistant benign prostatic hyperplasia (BPH) were reviewed retrospectively. Patients were...